Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease : a potential noninvasive marker of healing coronary endothelium

Cholesterol lowering over 1- to 3-year trials is associated with modest regression or no progression of focal coronary artery stenoses compared with progression in controls, a decrease in cardiac events proportionately more than the modest improvement in percent stenosis, and in experimental animals...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 1994-04, Vol.89 (4), p.1530-1538
Hauptverfasser:	GOULD, K. L, MARTUCCI, J. P, GOLDBERG, D. I, HESS, M. J, EDENS, R. P, LATIFI, R, DUCRICK, S. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Cardiology. Vascular system Cholesterol - blood Cholesterol, Dietary - administration & dosage Cholestyramine Resin - administration & dosage Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - therapy Coronary heart disease Dietary Fats - administration & dosage Dipyridamole Female Food, Formulated Heart Heart - diagnostic imaging Humans Image Processing, Computer-Assisted Lovastatin - therapeutic use Male Medical sciences Parenteral Nutrition, Total Time Factors Tomography, Emission-Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!